1. Home
  2. BLCO vs STNE Comparison

BLCO vs STNE Comparison

Compare BLCO & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • STNE
  • Stock Information
  • Founded
  • BLCO 1853
  • STNE 2012
  • Country
  • BLCO Canada
  • STNE Cayman Islands
  • Employees
  • BLCO N/A
  • STNE N/A
  • Industry
  • BLCO Ophthalmic Goods
  • STNE EDP Services
  • Sector
  • BLCO Health Care
  • STNE Technology
  • Exchange
  • BLCO Nasdaq
  • STNE Nasdaq
  • Market Cap
  • BLCO 4.9B
  • STNE 4.0B
  • IPO Year
  • BLCO 2022
  • STNE 2018
  • Fundamental
  • Price
  • BLCO $15.23
  • STNE $18.65
  • Analyst Decision
  • BLCO Hold
  • STNE Buy
  • Analyst Count
  • BLCO 11
  • STNE 8
  • Target Price
  • BLCO $15.80
  • STNE $16.56
  • AVG Volume (30 Days)
  • BLCO 492.5K
  • STNE 4.4M
  • Earning Date
  • BLCO 10-29-2025
  • STNE 11-11-2025
  • Dividend Yield
  • BLCO N/A
  • STNE N/A
  • EPS Growth
  • BLCO N/A
  • STNE N/A
  • EPS
  • BLCO N/A
  • STNE N/A
  • Revenue
  • BLCO $4,891,000,000.00
  • STNE $2,526,103,178.00
  • Revenue This Year
  • BLCO $8.27
  • STNE $21.73
  • Revenue Next Year
  • BLCO $5.73
  • STNE $6.95
  • P/E Ratio
  • BLCO N/A
  • STNE N/A
  • Revenue Growth
  • BLCO 8.81
  • STNE 19.78
  • 52 Week Low
  • BLCO $10.45
  • STNE $7.72
  • 52 Week High
  • BLCO $21.69
  • STNE $18.78
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 59.83
  • STNE 77.69
  • Support Level
  • BLCO $15.00
  • STNE $15.96
  • Resistance Level
  • BLCO $15.50
  • STNE $18.15
  • Average True Range (ATR)
  • BLCO 0.34
  • STNE 0.53
  • MACD
  • BLCO 0.02
  • STNE 0.19
  • Stochastic Oscillator
  • BLCO 72.03
  • STNE 96.34

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: